Article

Substrate oxidation during exercise: Type 2 diabetes is associated with a decrease in lipid oxidation and an earlier shift towards carbohydrate utilization

CHU de Montpellier, Service central de Physiologie Clinique, Unité d'Exploration Métabolique (CERAMM), Hôpital Lapeyronie, 34000 Montpellier, France.
Diabetes & Metabolism (Impact Factor: 2.85). 01/2007; 32(6):604-10. DOI: 10.1016/S1262-3636(07)70315-4
Source: PubMed

ABSTRACT Exercise is a recommended treatment for type 2 diabetes but the actual pattern of metabolic adaptation to exercise in this disease is poorly known and not taken in account in the protocols used. Metabolic defects involved in the pathways of substrate oxidation were described in type 2 diabetes. We hypothesized that type 2 diabetes, regardless of age, gender, training status and weight, could influence by its own the balance of substrates at exercise.
30 sedentary type 2 diabetic subjects and 38 sedentary matched control subjects were recruited. We used exercise calorimetry to determine lipid and carbohydrate oxidation rates. We calculated two parameters quantifying the balance of substrates induced by increasing exercise intensity: the maximal lipid oxidation point (PLipoxMax) and the Crossover point (COP), intensity from which the part of carbohydrate utilization providing energy becomes predominant on lipid oxidation.
Lipid oxidation was lower in the diabetic group, independent of exercise intensity. PLipoxMax and COP were lower in the diabetic group [PLipoxMax=25.3+/-1.4% vs. 36.6+/-1.7% %Wmax (P<0.0001)] - COP =24.2+/-2.2% vs. 38.8+/-1.9% %Wmax (P<0.0001).
Type 2 diabetes is associated with a decrease in lipid oxidation at exercise and a shift towards a predominance of carbohydrate oxidation for exercise intensities lower than in control subjects. Taking into account these alterations could provide a basis for personalizing training intensity.

Download full-text

Full-text

Available from: Jean Frederic Brun, Jul 25, 2015
0 Followers
 · 
101 Views
  • Source
    • "MFO is an index obtained at low to moderate exercise intensities (ranging from 33 to 65% VO 2 max) 10—14 during a submaximal graded exercise. Several studies have reported a reduced MFO in obese people [15] and in people with T2DM [16] and metabolic syndrome [17]. Therefore, these studies have suggested that MFO and insulin resistance may be strongly related. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: The hallmark features of obesity include insulin resistance and an impaired ability to oxidize lipids. As compared to exercise training, it remains relatively unclear if diet-induced weight loss can also induce fat metabolism. This study was undertaken to examine the effects of diet-induced weight loss on fat metabolism during a single session of exercise in middle-aged obese men. Methods: Fifteen obese men who were otherwise healthy (average age of 53.5 ± 6.9 yr and average body mass index of 27.8 ± 1.6 kg/m(2)) participated in a 12-wk weight loss program primarily consisting of dietary modification. Maximal fat oxidation (MFO) rates, MFO per lean body mass (MFOLBM) and insulin resistance (HOMA-IR) were measured before and after the program. Participants performed a 24-min graded exercise test on a cycle ergometer, with 15-W increments every 4 min. Expired gas analysis was performed by indirect calorimetry, and nonprotein respiratory quotient equations were used to calculate fat oxidation rates. Results: The weight (-8.3 ± 3.8 kg), fat mass (-4.5 ± 1.9 kg), and lean body mass (-3.8 ± 2.4 kg) (P < 0.001 for all measurements) of the participants were decreased at the end of the 12-wk program. The MFO tended to increase by 19% (P = 0.08) and MFOLBM significantly increased by 28.8% (P = 0.02). Although insulin resistance also significantly decreased by 49% (P < 0.001), changes in fat oxidation variables did not correlate with changes in insulin resistance. Conclusion: Diet-induced weight loss improves fat metabolism with the improvement in insulin resistance.:
    Obesity Research & Clinical Practice 04/2012; 6(2):e91-e174. DOI:10.1016/j.orcp.2011.06.003 · 0.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: L’obésité est un véritable problème de santé publique, qui peut induire, à elle seule, ou du fait des comorbidités associées, des incapacités et un handicap important. Dans les pays développés, la prévalence du diabète de type 2 (DT2) a considérablement augmenté, de façon presque superposable à celle de l’obésité. Chez ces sujets, l’activité physique (AP), associée aux modifications des habitudes alimentaires, est reconnue comme un des principes de base de la prise en charge pour limiter l’insulinorésistance, atteindre un bon contrôle glycémique, et d’améliorer le profil de risque. La connaissance de la physiologie du métabolisme musculaire à l’exercice permet de comprendre les principales perturbations métaboliques engendrées par l’obésité et le DT2 pouvant gêner le réentraînement et les effets bénéfiques de l’exercice sur ces dernières. Nous envisagerons ensuite les effets connus de l’exercice sur le poids, l’insulinorésistance, le DT2 et les facteurs de risque cardiovasculaires associés. Nous rappellerons également brièvement les potentielles interactions entre les thérapeutiques médicamenteuses et l’AP, ainsi que la conduite à tenir dans ces circonstances. Par la suite, nous aborderons les recommandations concernant la prescription de l’exercice en termes d’intensité, de type et de durée, et l’influence du stade de la maladie et des comorbidités sera discutée. En pratique, un test d’effort préalable est le plus souvent recommandé afin d’écarter toute contre-indication cardiologique et de personnaliser l’entraînement en fonction de la tolérance à l’effort. La prescription devra tenir également compte des habitudes de vie, ainsi que des préférences des patients, afin d’obtenir une adhérence optimale au long court. Du fait de la nécessité fréquente de soutien motivationnel et psychocomportemental, il apparaît nécessaire de développer des réseaux de prise en charge adaptés aux différents types de patients (ambulatoires, hospitalisés après complications métaboliques ou cardiovasculaires, patients polydéficients).
    La Lettre de médecine physique et de réadaptation 03/2012; 28(1). DOI:10.1007/s11659-012-0303-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: Biological surveillance data was analyzed at a plant which produced organic and inorganic tin chemicals. No chronic health problems related to occupational exposures were detected by biological testing history or physical examination. A statistical evaluation of biological values was conducted in an attempt to detect any significant changes. The blood values of all workers were well within normal limits. Workers in both the organic and inorganic tin production areas of the plant were found to have statistically significant reductions (p<.05) of their Red Blood Cell count (RBC), Hemoglobin (Hgb) and Hematocrit (Hct) levels when compared with either a non-exposed or a control group. In both analyses, the changes in the blood values were too small to be of clinical concern.
    OCEANS; 10/1987
Show more